Editorial Board
Submit Manuscript
Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at publisher@longdom.org
Table of Contents
About the Journal
Index Copernicus Value 2015: 62.2
Andrology is the medical specialty that deals with male health, particularly related to male reproductive system and urological syndromes. The journal publishes significant new findings of basic and clinical research on male reproductive system.
Journal of Andrology- Open Access is a scientific journal including a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. Journal of Andrology- Open Access is one of the best Open Access journals of Scholarly publishing.
Andrology- Open Access aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
Andrology- Open Access is a peer reviewed journal, serving the International Scientific Community. This journal offers an Open Access platform to the authors to publish their research outcome.
Longdom Publishing is publishing 300 open access journals with the support of about 25000 editorial board members. Andrology Open Access is one among the scholarly publishing journals. Longdom Publishing is also pioneer and leading scientific event organizer, conducting 100 International Scientific Conferences per year worldwide and has already signed 100 scientific Associations to make health care and scientific information open access.
All proposals should be submitted to Online Submission System or send as an e-mail attachment to the Editorial Office at publisher@longdom.org
Fast Editorial Review Process
Andrology- Open Access is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
h-index
Articles published in Andrology-Open Access have been cited by esteemed scholars and scientists all around the world. Andrology-Open Access has got h-index 9 , which means every article in Andrology-Open Access has got 9 average citations.
Journal Highlights
Current Issue Highlights
Research Article
Assessing Satisfaction of Erectile Dysfunction Patients after Using 5 mg Once Daily Tadalafil for 30 Days
Adel Mohammed Al Najjar*, Mohammed Ali Al Hothi, Mohammed Haider Aldholae, Ali Ahmed Al Zaazaai, Dhaifullah Jayed, Abdulsalam Mohammed Al-Mekdad, Saeed Al-Bahlooli and Aziz Saleh Alzendani
Research Article
Phase-III Clinical Trial with an Intravasal Once Injectable Non-Hormonal Male Contraceptive-Reversible Inhibition of Sperm under Guidance (RISUG)
Radhey Shyam Sharma*, Ajit Kumar Mathur, Hem Chandra Das, Balbir Singh Shah, Arvind Goyal, Kuldeep Chander Sharma, Subhash Abrol, Balram Sahoo, Nirmal Kumar Lohiya and Trilok Chand Sadasukhi
Research Article
Lifestyle Factors and Laboratory Sperm Processing Techniques Correlation with Sperm DNA Fragmentation Index, Oxidative Stress Adducts and High DNA Stainability
Alicia Lennea Broussard*, Benjamin Leader, Edna Tirado, Helena Russell, Hind Beydoun, Robert Colver, Laura Reuter, Bradford Bopp, Matthew Will, Erica Anspach Will and Glen Adaniya